Marshall Wace North America’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-365,866
| Closed | -$541K | – | 1558 |
|
|
2020
Q1 | $541K | Buy |
+365,866
| New | +$541K | ﹤0.01% | 740 |
|
|
2019
Q4 | – | Sell |
-8,726
| Closed | -$45K | – | 1680 |
|
|
2019
Q3 | $45K | Sell |
8,726
-14,152
| -62% | -$73K | ﹤0.01% | 1172 |
|
|
2019
Q2 | $164K | Sell |
22,878
-99,914
| -81% | -$716K | ﹤0.01% | 1053 |
|
|
2019
Q1 | $1.63M | Buy |
122,792
+116,135
| +1,745% | +$1.54M | 0.01% | 558 |
|
|
2018
Q4 | $52K | Buy |
+6,657
| New | +$52K | ﹤0.01% | 1243 |
|
|
2017
Q3 | – | Sell |
-40,416
| Closed | -$242K | – | 1557 |
|
|
2017
Q2 | $242K | Buy |
+40,416
| New | +$242K | ﹤0.01% | 1193 |
|